5 - All research
Permanent URI for this communityhttps://hdl.handle.net/2164/705
Browse
3 results
Search Results
Item EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulation(2024-07-01) Cooper, Rachel S.; Sutherland, Catherine; Smith, Linda M.; Cowan, Graeme; Barnett, Mark; Mitchell, Donna; McLean, Colin; Imlach, Stuart; Hayes, Alan; Zahra, Sharon; Manchanayake, Champa; Vickers, Mark; Graham, Gerry; McGowan, Neil; Turner, Marc L; Campbell, John D M; Fraser, Alasdair R; University of Aberdeen.Applied MedicineItem KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection(2021-05-04) Caduff, Nicole; McHugh, Donal; Rieble, Lisa; Forconi, Catherine S.; Ong'echa, John M.; Oluoch, Peter O.; Raykova, Ana; Murer, Anita; Böni, Michelle; Zuppiger, Lara; Schulz, Thomas F.; Blackbourn, David J.; Chijioke, Obinna; Moormann, Ann M.; Münz, Christian; University of Aberdeen.Medical Sciences; University of Aberdeen.Institute of Medical SciencesItem Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease(2014-11) Vickers, Mark A.; Wilkie, Gwen M.; Robinson, Nicolas; Rivera, Nadja; Haque, Tanzina; Crawford, Dorothy H.; Barry, Jacqueline; Fraser, Neil; Turner, David M.; Robertson, Victoria; Dyer, Phil; Flanagan, Peter; Newlands, Helen R.; Campbell, John; Turner, Marc; University of Aberdeen.Applied Medicine